In honor of Gift of Sight month we're replaying this insightful episode with Mark Wuttke, CEO of Dopavision. In their own words, Dopavision is pioneering the development of innovative solutions that target the eye’s innate dopamine pathway to address unmet needs in ophthalmology using digitally delivered light.

Topics include:

The background to Dopavision
The pediatric Myopia vs adult Myopia markets
Patient experience using Dopavision
Changes to clinical trials and the mechanism of action
Plans for commercialization
Potential future applications to other ophthalmological conditions and neurological conditions
The future of OTC vs Rx

Guest Links and Resources:

Connect with Mark Wuttke on LinkedIn
Visit Dopavision
Listen to Digital Therapeutics for Pediatrics, Oncology and Managing Pain with Francesca Wuttke
Episode PDF

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram